In the high-stakes world of pharmaceutical development, the path from bench to bedside is notoriously fraught with...
Chemotherapy and Targeted Therapy
In the early years of the smartphone revolution, the phrase "there’s an app for that" became the...
For over a decade, the American biotechnology sector has operated under the assumption that scientific brilliance, backed...
For decades, the medical community viewed metabolic dysfunction-associated steatohepatitis (MASH)—formerly known as NASH—as a “graveyard for drug...
In the high-stakes landscape of psychiatric pharmacology, few molecules have traveled as far as the chemical scaffold...
In a transformative period that has sent shockwaves through the biopharmaceutical sector, Dublin-based Alkermes has emerged as...
The global biopharmaceutical landscape is currently witnessing a massive infrastructure shift, characterized by record-breaking capital investments and...
The pharmaceutical and biotechnology sectors are undergoing a period of intense transformation, characterized by a recalibration of...
In a move that signals a significant shift in the landscape of early-stage biotechnology, Remix Therapeutics has...
SAN DIEGO — The biotechnology sector is experiencing a profound resurgence. Following a period of cooling sentiment...
